drugset
drugset / Trial / NCT06808802

To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokinetics in Healthy Participants

NCT06808802 ↗

Phase 1 Completed 30 enrolled Eli Lilly and Company
NaSequentialOpen-labelBasic science

Summary

The purpose of this study J1I-MC-GZQE is to measure the effect of retatrutide on the pharmacokinetics (PK) of metoprolol in healthy participants.

Timeline

Start
2025-02-03
Primary completion
2025-04-15
Completion
2025-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Metoprolol Other / unclassified — Oral
Subject Retatrutide Protein / enzyme biologic — Subcutaneous

Indications

No indication recorded.